Search

everythinglearnresearchcommunity

for

Search:↓

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Oral cyclosporin doesn't stop hair loss.

MK-5108 is safe and shows potential against tumors, especially alone.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

The compound was successfully made and shows potential for treating prostate cancer.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Suppressing ODC activity reduces tumor growth in hair follicles.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Topical finasteride helps regrow hair and reduce balding without side effects.

Cyproterone acetate effectively treats hirsutism and related conditions.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Thyroid receptor β can help develop new drugs to treat hair loss.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

A new compound that could treat various androgen-related conditions was created and analyzed.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

The treatment slightly increased hair growth and was safe for most women.

17α-estradiol lotion can reduce hair loss but doesn't promote new hair growth.

Switching to twice-weekly betamethasone led to full hair regrowth in 3 months without side effects.